Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10,375	13,338	6,182	5,037	7,966	819.35
Short-Term Investments	-	-	-	-	825.8	7,800
Cash & Short-Term Investments	10,375	13,338	6,182	5,037	8,792	8,619
Cash Growth	15.15%	115.74%	22.75%	-42.71%	2.00%	15.10%
Accounts Receivable	2,949	2,979	3,135	1,650	1,358	1,295
Other Receivables	2,275	846.75	1,498	2,430	1,329	741.78
Receivables	6,367	3,890	4,686	4,123	2,720	2,070
Inventory	16,503	13,118	11,224	13,290	8,856	7,006
Prepaid Expenses	-	103.21	93.42	156.09	262.2	70.31
Other Current Assets	459.93	544.78	1,076	593.62	1,199	666.78
Total Current Assets	33,704	30,993	23,262	23,199	21,829	18,432
Property, Plant & Equipment	16,243	15,636	14,253	13,375	11,989	10,006
Other Intangible Assets	0.67	0.83	1.25	12.68	26.9	49.02
Other Long-Term Assets	48.33	47.41	23.69	13.49	11.74	12.1
Total Assets	50,154	46,816	37,651	36,693	33,920	28,568

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	12,387	1,885	2,054	2,015	2,045	1,328
Accrued Expenses	-	7,306	6,172	4,936	4,212	4,587
Short-Term Debt	-	-	-	-	-	15.78
Current Portion of Leases	90.9	158.3	22.68	105.99	120.21	93.74
Current Income Taxes Payable	-	246.96	-	-	-	-
Current Unearned Revenue	-	362.3	394.39	610.97	565.96	460.42
Other Current Liabilities	884.67	3,418	3,017	9,167	7,664	2,858
Total Current Liabilities	13,363	13,376	11,660	16,835	14,607	9,343
Long-Term Leases	309.9	329.68	29.55	52.23	127.08	133.94
Pension & Post-Retirement Benefits	435.01	494.94	1,184	1,049	1,580	1,466
Long-Term Deferred Tax Liabilities	1,281	989.97	1,053	519.57	499.66	269.74
Total Liabilities	15,389	15,191	13,927	18,456	16,814	11,213

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	979	979	979	979	979	979
Retained Earnings	31,341	28,573	20,995	15,821	15,068	15,483
Comprehensive Income & Other	2,446	2,074	1,750	1,437	1,059	892.15
Shareholders' Equity	34,766	31,625	23,725	18,237	17,106	17,355
Total Liabilities & Equity	50,154	46,816	37,651	36,693	33,920	28,568

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	400.8	487.98	52.23	158.22	247.29	243.46
Net Cash (Debt)	9,974	12,850	6,130	4,878	8,545	8,376
Net Cash Growth	16.32%	109.61%	25.66%	-42.91%	2.01%	25.53%
Net Cash Per Share	101.88	131.25	62.62	49.83	87.28	85.56
Filing Date Shares Outstanding	97.88	97.9	97.9	97.9	97.9	97.9
Total Common Shares Outstanding	97.88	97.9	97.9	97.9	97.9	97.9
Working Capital	20,341	17,617	11,601	6,364	7,222	9,089
Book Value Per Share	355.18	323.04	242.33	186.28	174.73	177.27
Tangible Book Value	34,765	31,625	23,723	18,225	17,079	17,306
Tangible Book Value Per Share	355.17	323.03	242.32	186.16	174.45	176.77
Land	-	23.4	23.4	23.4	23.4	23.4
Buildings	-	1,012	1,012	1,055	786.79	582.35
Machinery	-	23,454	20,385	18,096	17,018	14,207
Construction In Progress	-	2,313	2,859	2,804	1,860	1,726

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error